Moderna, WHO set for vaccine clash as patents threaten mRNA use

Moderna is heading for a clash with the South African government and the World Health Organization over patent claims that vaccine advocates say could threaten the continent’s access to Covid-19 shots.

Medecins Sans Frontiers and other health and relief groups are calling on the vaccine-maker to abandon three patent applications filed years ago in South Africa, saying they could impede a WHO-backed effort to make messenger RNA shots for low-income countries at a hub in Cape Town.

The patents effectively give Moderna the right to stop anyone from making or selling an mRNA vaccine in South Africa, said Charles Gore, the director